Coronavirus Disease 2019-Related Fulminant Idiopathic Intracranial Hypertension

Abstract

Idiopathic intracranial hypertension or pseudotumor cerebri syndrome (PTCS) is defined as an increase in intracranial pressure (ICP) without an identifiable and/or structural cause or abnormal cerebrospinal fluid content. The most common symptoms of PTCS include headache, vomiting, pulsatile tinnitus, blurred vision, and diplopia. In 2 to 3% of PTCS patients, severe and rapidly progressive vision loss may develop within 1 month since symptoms begin; this clinical condition is usually defined as fulminant idiopathic intracranial hypertension (FIIH). This study presented a patient admitted to the hospital with headache and blurred vision, who also had high severe acute respiratory syndrome coronavirus 2 infections total antibody level and was treated with a lumboperitoneal shunt due to medical treatment-resistant increased ICP. We also reviewed similar cases previously reported in the literature. To the best of our knowledge, no children affected with coronavirus 2019 related to FIIH and requiring surgical treatment have been yet reported in the literature.

Keywords

COVID-19 - fulminant idiopathic intracranial hypertension - pseudotumor cerebri

• References

• 1 Gaier ED, Heidary G. Pediatric idiopathic intracranial hypertension. Semin Neurol 2019; 39 (06) 704-710
• 2 Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81 (13) 1159-1165
• 3 Juhász J, Hensler J, Jansen O. MRI-findings in idiopathic intracranial hypertension (pseudotumor cerebri). Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 2021; 193 (11) 1269-1276
• 4 Kuzan BN, Ilgın C, Kuzan TY. et al. Accuracy and reliability of magnetic resonance imaging in the diagnosis of idiopathic intracranial hypertension. Eur J Radiol 2022; 155: 110491
• 5 Bouffard MA. Fulminant idiopathic intracranial hypertension. Curr Neurol Neurosci Rep 2020; 20 (04) 8
• 6 Jiramongkolchai K, Buckley EG, Bhatti MT. et al. Temporary lumbar drain as treatment for pediatric fulminant idiopathic intracranial hypertension. J Neuroophthalmol 2017; 37 (02) 126-132
• 7 Chang MY, Yim CK, Borchert MS, Frasern C, Mollan S. Increase in pediatric pseudotumor cerebri syndrome emergency department visits, inpatient admissions, and surgeries during the COVID-19 pandemic. J Neuroophthalmol 2022; 42 (01) e87-e92
• 8 Baccarella A, Linder A, Spencer R. et al. Increased intracranial pressure in the setting of multisystem inflammatory syndrome in children, associated with COVID-19. Pediatr Neurol 2021; 115: 48-49
• 9 Khalid MF, Micieli JA. Idiopathic intracranial hypertension associated with SARS-CoV-2 B. 1.1. 7 variant of concern. Can J Neurol Sci 2022; 49 (03) 472-473
• 10 Mukharesh L, Bouffard MA, Fortin E. et al. Pseudotumor cerebri syndrome with COVID-19: a case series. J Neuroophthalmol 2022; 42 (03) e545-e547
• 11 Bilen NM, Sahbudak Bal Z, Yildirim Arslan S, Kanmaz S, Kurugol Z, Ozkinay F. Multisystem inflammatory syndrome in children presenting with pseudotumor cerebri and a review of the literature. Pediatr Infect Dis J 2021; 40 (12) e497-e500
• 12 Sofuoğlu Aİ, Akçay N, Şevketoğlu E, Bektaş G. Pseudotumor cerebri syndrome as a neurologic involvement of multisystem inflammatory syndrome in children: a case report. J Trop Pediatr 2021; 67 (04) fmab075
• 13 Verkuil LD, Liu GT, Brahma VL, Avery RA. Pseudotumor cerebri syndrome associated with MIS-C: a case report. Lancet 2020; 396 (10250): 532
• 14 Krueger MB, Montenegro RC, de Araújo Coimbra PP. et al. A wide spectrum of neurological manifestations in pediatrics patients with the COVID-19 infection: a case series. J Neurovirol 2021; 27 (05) 782-786
• 15 Insuga VS, Cantarín-Extremera V, Solís-Muñoz I. et al. Pseudotumor cerebri caused by SARS-CoV-2 infection in a boy. J Pediatr Neurol 2021; 19: 207-209
• 16 Divya K, Indumathi C, Vikrant K, Padmanaban S. Pseudotumor cerebri complicating multisystem inflammatory syndrome in a child. J Curr Ophthalmol 2021; 33 (03) 358-362
• 17 Talebian A, Soltani B, Aghadoost D, Azadbakht J, Rezaee A, Abbasy Z. Association between novel coronavirus disease 2019 (COVID-19) and idiopathic intracranial hypertension. Arch Pediatr Infect Dis 2021; (e-pub ahead of print).
• 18 Becker AE, Chiotos K, McGuire JL, Bruins BB, Alcamo AM. Intracranial hypertension in multisystem inflammatory syndrome in children. J Pediatr 2021; 233: 263-267
• 19 Sheldon CA, Paley GL, Xiao R. et al. Pediatric idiopathic intracranial hypertension: age, gender, and anthropometric features at diagnosis in a large, retrospective, multisite cohort. Ophthalmology 2016; 123 (11) 2424-2431
• 20 Salpietro V, Ruggieri M, Sancetta F. et al. New insights on the relationship between pseudotumor cerebri and secondary hyperaldosteronism in children. J Hypertens 2012; 30 (03) 629-630
• 21 Salpietro V, Chimenz R, Arrigo T, Ruggieri M. Pediatric idiopathic intracranial hypertension and extreme childhood obesity: a role for weight gain. J Pediatr 2013; 162 (05) 1084
• 22 Salpietro V, Ruggieri M. Pseudotumor cerebri pathophysiology: the likely role of aldosterone. Headache 2014; 54 (07) 1229
• 23 Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020; 11 (07) 995-998
• 24 Collantes MEV, Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG. Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can J Neurol Sci 2021; 48 (01) 66-76
• 25 Yang AC, Kern F, Losada PM. et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 2021; 595 (7868): 565-571
• 26 Boles S, Martinez-Rios C, Tibussek D, Pohl D. Infantile idiopathic intracranial hypertension: a case study and review of the literature. J Child Neurol 2019; 34 (13) 806-814